WS MANAGEMENT LLLP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
WS MANAGEMENT LLLP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$566,300
-22.7%
15,8850.0%0.05%
-24.6%
Q2 2023$732,775
+15.0%
15,8850.0%0.06%
-9.0%
Q1 2023$636,989
-13.4%
15,8850.0%0.07%
+6.3%
Q4 2022$735,952
+11.8%
15,8850.0%0.06%
+5.0%
Q3 2022$658,000
-30.6%
15,8850.0%0.06%
-22.1%
Q2 2022$948,000
-17.9%
15,8850.0%0.08%
+35.1%
Q1 2022$1,154,000
-13.6%
15,8850.0%0.06%
-46.2%
Q4 2021$1,336,000
-6.8%
15,8850.0%0.11%
-30.3%
Q3 2021$1,433,000
-5.4%
15,8850.0%0.15%
+2.0%
Q2 2021$1,515,000
-16.3%
15,8850.0%0.15%
-20.7%
Q1 2021$1,809,000
-21.7%
15,885
-4.8%
0.19%
-21.7%
Q4 2020$2,311,000
+68.4%
16,6920.0%0.24%
+62.2%
Q3 2020$1,372,000
+5.1%
16,6920.0%0.15%
-7.5%
Q2 2020$1,306,000
+50.3%
16,692
-14.7%
0.16%
+68.4%
Q1 2020$869,000
-1.0%
19,568
-4.8%
0.10%
+26.7%
Q4 2019$878,000
-0.1%
20,5530.0%0.08%
+8.7%
Q3 2019$879,000
-39.3%
20,553
-10.0%
0.07%
-26.6%
Q2 2019$1,449,000
-18.2%
22,824
-10.6%
0.09%
-12.1%
Q1 2019$1,771,000
+40.6%
25,528
-11.9%
0.11%
+75.4%
Q4 2018$1,260,000
-69.5%
28,972
-46.4%
0.06%
-55.1%
Q3 2018$4,130,000
-0.7%
54,1000.0%0.14%
+16.2%
Q2 2018$4,159,00054,1000.12%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders